ArriVent BioPharma, Inc. — Investor Relations & Filings
ArriVent BioPharma, Inc. is a clinical-stage biopharmaceutical company dedicated to identifying, developing, and commercializing differentiated medicines for patients with difficult-to-treat diseases, with an initial focus on oncology. The company's strategy involves forging strategic collaborations to in-license and advance promising drug candidates for global patient populations. Its lead development candidate is firmonertinib, a novel therapeutic for cancer. ArriVent's pipeline also includes other oncology therapeutics, such as next-generation antibody drug conjugates. The company leverages its team's extensive drug development and regulatory experience to design development strategies with clear paths to approval, aiming to address significant unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English | |
| 4 Filing | 2026-02-04 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
9 filings
| |||||
| 32132559 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32132554 | 4 Filing | 2026-02-04 | English | ||
| 32132552 | 4 Filing | 2026-02-04 | English | ||
| 32132551 | 4 Filing | 2026-02-04 | English | ||
| 32132541 | 4 Filing | 2026-02-04 | English | ||
| 32132535 | 4 Filing | 2026-02-04 | English | ||
| 32132566 | 4 Filing | 2026-02-03 | English | ||
| 32132539 | SCHEDULE 13G/A Filing | 2026-01-30 | English | ||
| 13482406 | Major Shareholding Notification 2026 | 2026-01-21 | English | ||
|
2025
6 filings
| |||||
| 13482410 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13482450 | 10-Q | 2025-11-10 | English | ||
| 13482457 | 8-K | 2025-11-10 | English | ||
| 13482461 | Major Shareholding Notification 2025 | 2025-11-05 | English | ||
| 13482471 | Major Shareholding Notification 2025 | 2025-10-30 | English | ||
| 13482465 | Major Shareholding Notification 2025 | 2025-10-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abliva
Biopharmaceutical company developing medicines for primary …
|
ABLI | SE | Manufacturing |
|
AB Science
Researches and develops protein kinase inhibitors for human…
|
AB | FR | Manufacturing |
|
ABVC BIOPHARMA, INC.
Develops botanical drugs and medical devices for oncology, …
|
ABVC | US | Manufacturing |
|
ACADIA PHARMACEUTICALS INC
Biopharmaceutical company developing medicines for CNS diso…
|
ACAD | US | Manufacturing |
|
Access Bio, Inc.
Develops and manufactures in vitro diagnostic solutions for…
|
950130 | IN | Manufacturing |
|
Accretion Nutraveda Limited
Develops and manufactures pharmaceutical, nutraceutical, an…
|
544694 | IN | Manufacturing |
|
Accretion Pharmaceuticals Limited
Develops and manufactures therapeutic formulations across d…
|
ACCPL | IN | Manufacturing |
|
Acerus Pharmaceuticals Corporation
Specialty pharmaceutical company focused on developing and …
|
ASPCF | CA | Manufacturing |
|
ACHIEVE LIFE SCIENCES, INC.
A late-stage pharmaceutical company developing a treatment …
|
ACHV | US | Manufacturing |
|
Achyut Healthcare Limited
Procures, trades, and manufactures pharmaceutical APIs and …
|
543499 | IN | Manufacturing |
ArriVent BioPharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32470/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32470 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32470 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32470 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32470}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ArriVent BioPharma, Inc. (id: 32470)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.